ID   GRIA4_RAT               Reviewed;         902 AA.
AC   P19493; Q64241;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   02-OCT-2024, entry version 203.
DE   RecName: Full=Glutamate receptor 4 {ECO:0000305};
DE            Short=GluR-4;
DE            Short=GluR4;
DE   AltName: Full=AMPA-selective glutamate receptor 4;
DE   AltName: Full=GluR-D;
DE   AltName: Full=Glutamate receptor ionotropic, AMPA 4;
DE            Short=GluA4;
DE   Flags: Precursor;
GN   Name=Gria4 {ECO:0000312|RGD:61863}; Synonyms=Glur4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=2166337; DOI=10.1126/science.2166337;
RA   Keinaenen K., Wisden W., Sommer B., Werner P., Herb A., Verdoorn T.A.,
RA   Sakmann B., Seeburg P.H.;
RT   "A family of AMPA-selective glutamate receptors.";
RL   Science 249:556-560(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1977421; DOI=10.1016/0896-6273(90)90213-y;
RA   Bettler B., Boulter J., Hermans-Borgmeyer I., O'Shea-Greenfield A.,
RA   Deneris E.S., Moll C., Borgmeyer U., Hollmann M., Heinemann S.F.;
RT   "Cloning of a novel glutamate receptor subunit, GluR5: expression in the
RT   nervous system during development.";
RL   Neuron 5:583-595(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1699275; DOI=10.1126/science.1699275;
RA   Sommer B., Keinaenen K., Verdoorn T.A., Wisden W., Burnashev N., Herb A.,
RA   Koehler M., Takagi T., Sakmann B., Seeburg P.H.;
RT   "Flip and flop: a cell-specific functional switch in glutamate-operated
RT   channels of the CNS.";
RL   Science 249:1580-1585(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=1372042; DOI=10.1523/jneurosci.12-03-01010.1992;
RA   Gallo V., Upson L.M., Hayes W.P., Vyklicky L. Jr., Winters C.A.,
RA   Buonanno A.;
RT   "Molecular cloning and development analysis of a new glutamate receptor
RT   subunit isoform in cerebellum.";
RL   J. Neurosci. 12:1010-1023(1992).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, GLYCOSYLATION AT ASN-407 AND ASN-414, SUBCELLULAR
RP   LOCATION, FUNCTION, AND MUTAGENESIS OF ASN-407 AND ASN-414.
RX   PubMed=12603841; DOI=10.1046/j.1471-4159.2003.01611.x;
RA   Pasternack A., Coleman S.K., Fethiere J., Madden D.R., LeCaer J.P.,
RA   Rossier J., Pasternack M., Keinaenen K.;
RT   "Characterization of the functional role of the N-glycans in the AMPA
RT   receptor ligand-binding domain.";
RL   J. Neurochem. 84:1184-1192(2003).
RN   [6]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=1370372; DOI=10.1016/0896-6273(92)90120-3;
RA   Burnashev N., Monyer H., Seeburg P.H., Sakmann B.;
RT   "Divalent ion permeability of AMPA receptor channels is dominated by the
RT   edited form of a single subunit.";
RL   Neuron 8:189-198(1992).
RN   [7]
RP   INTERACTION WITH PICK1 (ISOFORM 3).
RX   PubMed=10027300; DOI=10.1016/s0896-6273(00)80689-3;
RA   Xia J., Zhang X., Staudinger J., Huganir R.L.;
RT   "Clustering of AMPA receptors by the synaptic PDZ domain-containing protein
RT   PICK1.";
RL   Neuron 22:179-187(1999).
RN   [8]
RP   PHOSPHORYLATION AT SER-862, INTERACTION WITH PRKCG, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12471040; DOI=10.1074/jbc.m205587200;
RA   Correia S.S., Duarte C.B., Faro C.J., Pires E.V., Carvalho A.L.;
RT   "Protein kinase C gamma associates directly with the GluR4 alpha-amino-3-
RT   hydroxy-5-methyl-4-isoxazole propionate receptor subunit. Effect on
RT   receptor phosphorylation.";
RL   J. Biol. Chem. 278:6307-6313(2003).
RN   [9]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH EPB41L1.
RX   PubMed=12574408; DOI=10.1523/jneurosci.23-03-00798.2003;
RA   Coleman S.K., Cai C., Mottershead D.G., Haapalahti J.-P., Keinaenen K.;
RT   "Surface expression of GluR-D AMPA receptor is dependent on an interaction
RT   between its C-terminal domain and a 4.1 protein.";
RL   J. Neurosci. 23:798-806(2003).
RN   [10]
RP   INTERACTION WITH CACNG5.
RX   PubMed=18817736; DOI=10.1016/j.neuron.2008.07.034;
RA   Kato A.S., Siuda E.R., Nisenbaum E.S., Bredt D.S.;
RT   "AMPA receptor subunit-specific regulation by a distinct family of type II
RT   TARPs.";
RL   Neuron 59:986-996(2008).
RN   [11]
RP   INTERACTION WITH CACNG5.
RX   PubMed=19234459; DOI=10.1038/nn.2266;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M., Cull-Candy S.G.;
RT   "Selective regulation of long-form calcium-permeable AMPA receptors by an
RT   atypical TARP, gamma-5.";
RL   Nat. Neurosci. 12:277-285(2009).
RN   [12]
RP   ERRATUM OF PUBMED:19234459.
RX   DOI=10.1038/nn0609-808c;
RA   Soto D., Coombs I.D., Renzi M., Zonouzi M., Farrant M., Cull-Candy S.G.;
RL   Nat. Neurosci. 12:808-808(2009).
RN   [13]
RP   SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19265014; DOI=10.1126/science.1167852;
RA   Schwenk J., Harmel N., Zolles G., Bildl W., Kulik A., Heimrich B.,
RA   Chisaka O., Jonas P., Schulte U., Fakler B., Kloecker N.;
RT   "Functional proteomics identify cornichon proteins as auxiliary subunits of
RT   AMPA receptors.";
RL   Science 323:1313-1319(2009).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-258, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24090084; DOI=10.1021/pr400783j;
RA   Parker B.L., Thaysen-Andersen M., Solis N., Scott N.E., Larsen M.R.,
RA   Graham M.E., Packer N.H., Cordwell S.J.;
RT   "Site-specific glycan-peptide analysis for determination of N-glycoproteome
RT   heterogeneity.";
RL   J. Proteome Res. 12:5791-5800(2013).
RN   [15] {ECO:0007744|PDB:3EN3, ECO:0007744|PDB:3EPE}
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 416-795 IN COMPLEX WITH GLUTAMATE
RP   AND DIHYDROKAINIC ACID, FUNCTION, AND SUBUNIT.
RX   PubMed=19102704; DOI=10.1021/bi8013196;
RA   Gill A., Birdsey-Benson A., Jones B.L., Henderson L.P., Madden D.R.;
RT   "Correlating AMPA receptor activation and cleft closure across subunits:
RT   crystal structures of the GluR4 ligand-binding domain in complex with full
RT   and partial agonists.";
RL   Biochemistry 47:13831-13841(2008).
RN   [16] {ECO:0007744|PDB:3FAS, ECO:0007744|PDB:3FAT}
RP   X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 415-796 IN COMPLEX WITH
RP   GLUTAMATE, AMPA BINDING, AND DISULFIDE BOND.
RX   PubMed=19022251; DOI=10.1016/j.febslet.2008.11.005;
RA   Kasper C., Frydenvang K., Naur P., Gajhede M., Pickering D.S.,
RA   Kastrup J.S.;
RT   "Molecular mechanism of agonist recognition by the ligand-binding core of
RT   the ionotropic glutamate receptor 4.";
RL   FEBS Lett. 582:4089-4094(2008).
RN   [17] {ECO:0007744|PDB:3KEI, ECO:0007744|PDB:3KFM}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 416-795 IN COMPLEX WITH GLUTAMATE
RP   AND DIHYDROKAINIC ACID, AND FUNCTION.
RX   PubMed=20107073; DOI=10.1523/jneurosci.4558-09.2010;
RA   Birdsey-Benson A., Gill A., Henderson L.P., Madden D.R.;
RT   "Enhanced efficacy without further cleft closure: reevaluating twist as a
RT   source of agonist efficacy in AMPA receptors.";
RL   J. Neurosci. 30:1463-1470(2010).
RN   [18] {ECO:0007744|PDB:5FWX}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 22-401 IN COMPLEX WITH GRIA2,
RP   SUBUNIT, DISULFIDE BOND, AND FUNCTION.
RX   PubMed=26966189; DOI=10.1126/science.aad3873;
RA   Herguedas B., Garcia-Nafria J., Cais O., Fernandez-Leiro R., Krieger J.,
RA   Ho H., Greger I.H.;
RT   "Structure and organization of heteromeric AMPA-type glutamate receptors.";
RL   Science 352:aad3873-aad3873(2016).
CC   -!- FUNCTION: Ionotropic glutamate receptor that functions as a ligand-
CC       gated cation channel, gated by L-glutamate and glutamatergic agonists
CC       such as alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
CC       (AMPA), quisqualic acid, and kainic acid (PubMed:12603841,
CC       PubMed:1372042, PubMed:19102704, PubMed:20107073, PubMed:2166337,
CC       PubMed:26966189). L-glutamate acts as an excitatory neurotransmitter at
CC       many synapses in the central nervous system and plays an important role
CC       in fast excitatory synaptic transmission (By similarity). Binding of
CC       the excitatory neurotransmitter L-glutamate induces a conformation
CC       change, leading to the opening of the cation channel, and thereby
CC       converts the chemical signal to an electrical impulse upon entry of
CC       monovalent and divalent cations such as sodium and calcium
CC       (PubMed:1370372, PubMed:19102704). The receptor then desensitizes
CC       rapidly and enters a transient inactive state, characterized by the
CC       presence of bound agonist (PubMed:19102704, PubMed:26966189). In the
CC       presence of CACNG8, shows resensitization which is characterized by a
CC       delayed accumulation of current flux upon continued application of L-
CC       glutamate (By similarity). {ECO:0000250|UniProtKB:P42262,
CC       ECO:0000250|UniProtKB:P48058, ECO:0000269|PubMed:12603841,
CC       ECO:0000269|PubMed:1370372, ECO:0000269|PubMed:1372042,
CC       ECO:0000269|PubMed:19102704, ECO:0000269|PubMed:20107073,
CC       ECO:0000269|PubMed:2166337, ECO:0000269|PubMed:26966189}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:1370372};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:1370372};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Mg(2+)(in) = Mg(2+)(out); Xref=Rhea:RHEA:29827,
CC         ChEBI:CHEBI:18420; Evidence={ECO:0000269|PubMed:1370372};
CC   -!- SUBUNIT: Homotetramer or heterotetramer of pore-forming glutamate
CC       receptor subunits (PubMed:19102704, PubMed:26966189). Tetramers may be
CC       formed by the dimerization of dimers (PubMed:26966189). Interacts with
CC       EPB41L1 via its C-terminus (PubMed:12574408). Isoform 3 interacts with
CC       PICK1 (PubMed:10027300). Found in a complex with GRIA1, GRIA2, GRIA3,
CC       CNIH2, CNIH3, CACNG2, CACNG3, CACNG4, CACNG5, CACNG7 and CACNG8
CC       (PubMed:19265014). Interacts with CACNG5 and PRKCG (PubMed:12471040,
CC       PubMed:18817736, PubMed:19234459). Found in a complex with GRIA1,
CC       GRIA2, GRIA3, DLG4, CACNG8 and CNIH2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9Z2W8, ECO:0000269|PubMed:10027300,
CC       ECO:0000269|PubMed:12471040, ECO:0000269|PubMed:12574408,
CC       ECO:0000269|PubMed:18817736, ECO:0000269|PubMed:19102704,
CC       ECO:0000269|PubMed:19234459, ECO:0000269|PubMed:19265014,
CC       ECO:0000269|PubMed:26966189}.
CC   -!- INTERACTION:
CC       P19493; P19493: Gria4; NbExp=2; IntAct=EBI-7761834, EBI-7761834;
CC       P19493; P97879: Grip1; NbExp=3; IntAct=EBI-7761834, EBI-936113;
CC       P19493; P49185: Mapk8; NbExp=2; IntAct=EBI-7761834, EBI-7456505;
CC       P19493-2; P19491-2: Gria2; NbExp=2; IntAct=EBI-15852899, EBI-15817825;
CC       P19493-2; P19493-2: Gria4; NbExp=4; IntAct=EBI-15852899, EBI-15852899;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12574408,
CC       ECO:0000269|PubMed:12603841}; Multi-pass membrane protein. Postsynaptic
CC       cell membrane; Multi-pass membrane protein. Cell projection, dendrite
CC       {ECO:0000269|PubMed:12471040}. Postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:P42262}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P42262}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Flop;
CC         IsoId=P19493-1; Sequence=Displayed;
CC       Name=2; Synonyms=Flip;
CC         IsoId=P19493-2; Sequence=VSP_000123, VSP_000124, VSP_000125;
CC       Name=3; Synonyms=4C flop;
CC         IsoId=P19493-3; Sequence=VSP_000126;
CC   -!- TISSUE SPECIFICITY: Detected in cerebellum.
CC       {ECO:0000269|PubMed:1372042}.
CC   -!- DOMAIN: The M4 transmembrane segment mediates tetramerization and is
CC       required for cell surface expression. {ECO:0000250|UniProtKB:P42262}.
CC   -!- PTM: Palmitoylated. Depalmitoylated upon L-glutamate stimulation.
CC       ZDHHC3/GODZ specifically palmitoylates Cys-611, which leads to Golgi
CC       retention and decreased cell surface expression. In contrast, Cys-837
CC       palmitoylation does not affect cell surface expression but regulates
CC       stimulation-dependent endocytosis. {ECO:0000250|UniProtKB:P23819}.
CC   -!- PTM: Phosphorylated at Ser-862 by PRKCG; phosphorylation increases
CC       plasma membrane-associated GRI4 expression.
CC       {ECO:0000269|PubMed:12471040}.
CC   -!- MISCELLANEOUS: The postsynaptic actions of L-glutamate are mediated by
CC       a variety of receptors that are named according to their selective
CC       agonists (PubMed:12603841, PubMed:1372042, PubMed:2166337). This
CC       receptor binds AMPA (quisqualate) > L-glutamate > kainate
CC       (PubMed:12603841, PubMed:1372042, PubMed:2166337).
CC       {ECO:0000269|PubMed:12603841, ECO:0000269|PubMed:1372042,
CC       ECO:0000269|PubMed:2166337}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. GRIA4 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M36421; AAA41246.1; -; mRNA.
DR   EMBL; M85037; AAA41242.1; -; mRNA.
DR   EMBL; M38063; AAA63481.1; -; mRNA.
DR   EMBL; S94371; AAB21763.1; -; mRNA.
DR   PIR; A44839; A44839.
DR   PIR; D40170; D40170.
DR   RefSeq; NP_001106655.1; NM_001113184.1.
DR   RefSeq; NP_058959.2; NM_017263.2.
DR   PDB; 3EN3; X-ray; 2.43 A; A=416-528, A=654-795.
DR   PDB; 3EPE; X-ray; 1.85 A; A/B=416-528, A/B=654-795.
DR   PDB; 3FAS; X-ray; 1.40 A; A/B=415-528, A/B=654-796.
DR   PDB; 3FAT; X-ray; 1.90 A; A/B/C=415-528, A/B/C=654-796.
DR   PDB; 3KEI; X-ray; 1.90 A; A/B=416-528, A/B=654-795.
DR   PDB; 3KFM; X-ray; 2.20 A; A=416-528, A=654-795.
DR   PDB; 4GPA; X-ray; 2.25 A; A=22-401.
DR   PDB; 5FWX; X-ray; 2.50 A; B/D=22-401.
DR   PDBsum; 3EN3; -.
DR   PDBsum; 3EPE; -.
DR   PDBsum; 3FAS; -.
DR   PDBsum; 3FAT; -.
DR   PDBsum; 3KEI; -.
DR   PDBsum; 3KFM; -.
DR   PDBsum; 4GPA; -.
DR   PDBsum; 5FWX; -.
DR   AlphaFoldDB; P19493; -.
DR   EMDB; EMD-20332; -.
DR   EMDB; EMD-20717; -.
DR   EMDB; EMD-20732; -.
DR   SMR; P19493; -.
DR   BioGRID; 248252; 35.
DR   CORUM; P19493; -.
DR   DIP; DIP-41142N; -.
DR   IntAct; P19493; 5.
DR   MINT; P19493; -.
DR   STRING; 10116.ENSRNOP00000009542; -.
DR   BindingDB; P19493; -.
DR   ChEMBL; CHEMBL3505; -.
DR   DrugCentral; P19493; -.
DR   TCDB; 1.A.10.1.2; the glutamate-gated ion channel (gic) family of neurotransmitter receptors.
DR   GlyCosmos; P19493; 6 sites, 9 glycans.
DR   GlyGen; P19493; 6 sites, 9 N-linked glycans (1 site).
DR   iPTMnet; P19493; -.
DR   PhosphoSitePlus; P19493; -.
DR   SwissPalm; P19493; -.
DR   PaxDb; 10116-ENSRNOP00000009542; -.
DR   GeneID; 29629; -.
DR   KEGG; rno:29629; -.
DR   UCSC; RGD:61863; rat. [P19493-1]
DR   AGR; RGD:61863; -.
DR   CTD; 2893; -.
DR   RGD; 61863; Gria4.
DR   eggNOG; KOG1054; Eukaryota.
DR   InParanoid; P19493; -.
DR   OrthoDB; 511851at2759; -.
DR   PhylomeDB; P19493; -.
DR   Reactome; R-RNO-399710; Activation of AMPA receptors.
DR   Reactome; R-RNO-399719; Trafficking of AMPA receptors.
DR   Reactome; R-RNO-416993; Trafficking of GluR2-containing AMPA receptors.
DR   Reactome; R-RNO-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-RNO-8849932; Synaptic adhesion-like molecules.
DR   EvolutionaryTrace; P19493; -.
DR   PRO; PR:P19493; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0032281; C:AMPA glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IDA:ARUK-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0008328; C:ionotropic glutamate receptor complex; TAS:UniProtKB.
DR   GO; GO:0032983; C:kainate selective glutamate receptor complex; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; IMP:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0004971; F:AMPA glutamate receptor activity; IMP:RGD.
DR   GO; GO:0004970; F:glutamate-gated receptor activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; ISO:RGD.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IMP:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IMP:UniProtKB.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; ISO:RGD.
DR   GO; GO:0034392; P:negative regulation of smooth muscle cell apoptotic process; ISO:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IMP:UniProtKB.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   GO; GO:0050803; P:regulation of synapse structure or activity; TAS:UniProtKB.
DR   GO; GO:0060992; P:response to fungicide; IEP:RGD.
DR   GO; GO:0035249; P:synaptic transmission, glutamatergic; IBA:GO_Central.
DR   CDD; cd06388; PBP1_iGluR_AMPA_GluR4; 1.
DR   CDD; cd13727; PBP2_iGluR_AMPA_GluR4; 1.
DR   Gene3D; 1.10.287.70; -; 2.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 3.40.190.10; Periplasmic binding protein-like II; 2.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_Glu_rcpt_met.
DR   InterPro; IPR015683; Ionotropic_Glu_rcpt.
DR   InterPro; IPR001320; Iontro_rcpt_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   PANTHER; PTHR18966:SF100; GLUTAMATE RECEPTOR 4; 1.
DR   PANTHER; PTHR18966; IONOTROPIC GLUTAMATE RECEPTOR; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   SUPFAM; SSF53850; Periplasmic binding protein-like II; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Cell projection;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Lipoprotein; Membrane; Palmitate;
KW   Phosphoprotein; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..902
FT                   /note="Glutamate receptor 4"
FT                   /id="PRO_0000011540"
FT   TOPO_DOM        22..544
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        545..565
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        566..592
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        593..608
FT                   /note="Helical; Pore-forming"
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        609..611
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        612..617
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        618..638
FT                   /note="Helical"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        639..813
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        814..834
FT                   /note="Helical; Name=M4"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        835..902
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   BINDING         500
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:19022251,
FT                   ECO:0000269|PubMed:19102704, ECO:0000269|PubMed:20107073,
FT                   ECO:0007744|PDB:3EPE, ECO:0007744|PDB:3FAS,
FT                   ECO:0007744|PDB:3KEI"
FT   BINDING         502
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:19022251,
FT                   ECO:0000269|PubMed:19102704, ECO:0000269|PubMed:20107073,
FT                   ECO:0007744|PDB:3EPE, ECO:0007744|PDB:3FAS,
FT                   ECO:0007744|PDB:3KEI"
FT   BINDING         507
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:19022251,
FT                   ECO:0000269|PubMed:19102704, ECO:0000269|PubMed:20107073,
FT                   ECO:0007744|PDB:3EPE, ECO:0007744|PDB:3FAS,
FT                   ECO:0007744|PDB:3KEI"
FT   BINDING         676
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:19022251,
FT                   ECO:0000269|PubMed:19102704, ECO:0000269|PubMed:20107073,
FT                   ECO:0007744|PDB:3EPE, ECO:0007744|PDB:3FAS,
FT                   ECO:0007744|PDB:3KEI"
FT   BINDING         677
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:19022251,
FT                   ECO:0000269|PubMed:19102704, ECO:0000269|PubMed:20107073,
FT                   ECO:0007744|PDB:3EPE, ECO:0007744|PDB:3FAS,
FT                   ECO:0007744|PDB:3KEI"
FT   BINDING         727
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000269|PubMed:19022251,
FT                   ECO:0000269|PubMed:19102704, ECO:0000269|PubMed:20107073,
FT                   ECO:0007744|PDB:3EPE, ECO:0007744|PDB:3FAS,
FT                   ECO:0007744|PDB:3KEI"
FT   MOD_RES         862
FT                   /note="Phosphoserine; by PKC/PRKCG"
FT                   /evidence="ECO:0000269|PubMed:12471040"
FT   LIPID           611
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P42262"
FT   LIPID           837
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P42262"
FT   CARBOHYD        52
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        56
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        258
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PubMed:24090084"
FT   CARBOHYD        371
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        407
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12603841"
FT   CARBOHYD        414
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12603841"
FT   DISULFID        84..331
FT                   /evidence="ECO:0000269|PubMed:26966189"
FT   DISULFID        740..795
FT                   /evidence="ECO:0000269|PubMed:19022251"
FT   VAR_SEQ         765..767
FT                   /note="GNA -> RTP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1699275,
FT                   ECO:0000303|PubMed:1977421"
FT                   /id="VSP_000123"
FT   VAR_SEQ         776..780
FT                   /note="NEQGL -> SEAGV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1699275,
FT                   ECO:0000303|PubMed:1977421"
FT                   /id="VSP_000124"
FT   VAR_SEQ         797..801
FT                   /note="SGGGD -> PKDSG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1699275,
FT                   ECO:0000303|PubMed:1977421"
FT                   /id="VSP_000125"
FT   VAR_SEQ         849..902
FT                   /note="LTFSEATRNKARLSITGSVGENGRVLTPDCPKAVHTGTAIRQSSGLAVIASD
FT                   LP -> VAKSAQTFNPTSSQNTHNLATYREGYNVYGTESIKI (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1372042"
FT                   /id="VSP_000126"
FT   MUTAGEN         407
FT                   /note="N->Q: No effect on surface expression and channel
FT                   activity; when associated with Q-414."
FT                   /evidence="ECO:0000269|PubMed:12603841"
FT   MUTAGEN         414
FT                   /note="N->Q: No effect on surface expression and channel
FT                   activity; when associated with Q-407."
FT                   /evidence="ECO:0000269|PubMed:12603841"
FT   CONFLICT        111..112
FT                   /note="SA -> RR (in Ref. 2; AAA41242)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        454
FT                   /note="I -> S (in Ref. 2; AAA41242)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        734
FT                   /note="T -> I (in Ref. 2; AAA41242)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        855
FT                   /note="T -> I (in Ref. 2; AAA41242)"
FT                   /evidence="ECO:0000305"
FT   STRAND          25..33
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           38..52
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   TURN            57..59
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          61..70
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           76..88
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          92..96
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   TURN            100..102
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           103..112
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          116..119
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          129..133
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           139..148
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          153..158
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           165..175
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   TURN            176..178
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          180..185
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           191..204
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          208..212
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           215..228
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          236..239
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          241..243
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           244..246
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           250..255
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          258..263
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           270..279
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   TURN            284..286
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   TURN            288..291
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           296..317
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   HELIX           342..350
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          353..356
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          359..363
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          367..369
FT                   /evidence="ECO:0007829|PDB:5FWX"
FT   STRAND          373..380
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          383..391
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   TURN            392..394
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          395..398
FT                   /evidence="ECO:0007829|PDB:4GPA"
FT   STRAND          416..421
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   TURN            425..427
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          428..430
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           434..436
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           439..442
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          443..445
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           446..458
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          461..466
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   TURN            477..479
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           484..490
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          495..497
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           505..508
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          511..513
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          517..520
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          522..527
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           658..662
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          665..670
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          672..675
FT                   /evidence="ECO:0007829|PDB:3KEI"
FT   HELIX           676..683
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           687..698
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          705..707
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           708..717
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   TURN            718..720
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          721..727
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           728..735
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          742..746
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          752..754
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   STRAND          757..759
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           765..777
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   HELIX           780..789
FT                   /evidence="ECO:0007829|PDB:3FAS"
FT   TURN            790..792
FT                   /evidence="ECO:0007829|PDB:3FAS"
SQ   SEQUENCE   902 AA;  100758 MW;  873D1B4C710C4459 CRC64;
     MRIICRQIVL LFSGFWGLAM GAFPSSVQIG GLFIRNTDQE YTAFRLAIFL HNTSPNASEA
     PFNLVPHVDN IETANSFAVT NAFCSQYSRG VFAIFGLYDK RSVHTLTSFC SALHISLITP
     SFPTEGESQF VLQLRPSLRG ALLSLLDHYE WNCFVFLYDT DRGYSILQAI MEKAGQNGWH
     VSAICVENFN DVSYRQLLEE LDRRQEKKFV IDCEIERLQN ILEQIVSVGK HVKGYHYIIA
     NLGFKDISLE RFIHGGANVT GFQLVDFNTP MVTKLMDRWK KLDQREYPGS ETPPKYTSAL
     TYDGVLVMAE TFRSLRRQKI DISRRGNAGD CLANPAAPWG QGIDMERTLK QVRIQGLTGN
     VQFDHYGRRV NYTMDVFELK STGPRKVGYW NDMDKLVLIQ DMPTLGNDTA AIENRTVVVT
     TIMESPYVMY KKNHEMFEGN DKYEGYCVDL ASEIAKHIGI KYKIAIVPDG KYGARDADTK
     IWNGMVGELV YGKAEIAIAP LTITLVREEV IDFSKPFMSL GISIMIKKPQ KSKPGVFSFL
     DPLAYEIWMC IVFAYIGVSV VLFLVSRFSP YEWHTEEPED GKEGPSDQPP NEFGIFNSLW
     FSLGAFMQQG CDISPRSLSG RIVGGVWWFF TLIIISSYTA NLAAFLTVER MVSPIESAED
     LAKQTEIAYG TLDSGSTKEF FRRSKIAVYE KMWTYMRSAE PSVFTRTTAE GVARVRKSKG
     KFAFLLESTM NEYTEQRKPC DTMKVGGNLD SKGYGVATPK GSSLGNAVNL AVLKLNEQGL
     LDKLKNKWWY DKGECGSGGG DSKDKTSALS LSNVAGVFYI LVGGLGLAML VALIEFCYKS
     RAEAKRMKLT FSEATRNKAR LSITGSVGEN GRVLTPDCPK AVHTGTAIRQ SSGLAVIASD
     LP
//
